Marsh McLennan (MRSH) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
3 Feb, 2026Executive summary
Q2 2024 revenue grew 6% year-over-year to $6.2 billion, with net income of $1.1 billion and diluted EPS up 10% to $2.27; first half 2024 revenue reached $12.7 billion, up 8% year-over-year.
Adjusted operating income rose 11% to $1.7 billion in Q2, with adjusted EPS up 10% to $2.41 and operating margin expanding by 130 basis points to 29%.
Announced a 15% increase in quarterly dividend to $0.815 per share and completed $300 million in Q2 share repurchases, totaling $600 million year-to-date.
Multiple acquisitions completed in both Risk & Insurance Services and Consulting, including Cardano, Veritas Total Solutions, and Fisher Brown Bottrell Insurance.
Continued investment in innovation and talent, launching new digital and analytics solutions and focusing on ESG, cyber risk, and climate resilience.
Financial highlights
Q2 2024 consolidated revenue: $6.2B (+6% YoY); H1 2024: $12.7B (+8% YoY); Q2 net income: $1.1B; H1 net income: $2.5B.
Q2 adjusted operating margin: 29% (up 130 bps); Q2 GAAP EPS: $2.27, adjusted EPS: $2.41 (up 10%).
Six-month adjusted operating income: $3.7B (up 11% YoY); six-month adjusted EPS: $5.30 (up 12% YoY).
Operating cash flow for H1 2024 was $434M, down from $665M in H1 2023.
Free cash flow for LTM 2Q24 reached $3.6B, with a 17% CAGR since 2010.
Outlook and guidance
Expecting mid-single-digit or better underlying revenue growth, margin expansion, and strong adjusted EPS growth for full year 2024, assuming current macro conditions persist.
Margin expansion in the second half of 2024 is expected to be better than the first half.
Adjusted effective tax rate for 2024 projected between 25.5% and 26.5%.
Management expects strong positioning for the remainder of 2024, citing robust first-half results and continued investments.
Latest events from Marsh McLennan
- 2025 revenue up 10%, adjusted EPS up 9%, and $2.0B in share repurchases.MRSH
Q4 202527 Feb 2026 - Q3 revenue up 6%, strong segment growth, and $7.75B McGriff acquisition announced.MRSH
Q3 202419 Jan 2026 - Strong 2024 growth, record acquisitions, and margin expansion set up a positive 2025 outlook.MRSH
Q4 20249 Jan 2026 - Q1 2025 revenue up 9%, adjusted EPS up 5%, with strong segment growth and capital returns.MRSH
Q1 202519 Dec 2025 - Strong 2024 results, robust governance, and key votes on directors, pay, auditor, and equity plan.MRSH
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, pay, auditor, and incentive plan, all board-backed.MRSH
Proxy Filing1 Dec 2025 - Q2 2025 delivered 12% revenue growth, 11% EPS gain, and a 10% dividend increase.MRSH
Q2 20255 Nov 2025 - Q3 revenue up 11%, adjusted EPS up 11%, Thrive targets $400M savings, rebranding to Marsh.MRSH
Q3 202520 Oct 2025